IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Return
65.21%
This Quarter Return
+11.71%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$302M
AUM Growth
-$4.71M
(-1.5%)
Cap. Flow
-$13.5M
Cap. Flow
% of AUM
-4.45%
Top 10 Holdings %
Top 10 Hldgs %
44.95%
Holding
160
New
20
Increased
14
Reduced
32
Closed
33
Top Buys
| 1 |
Cidara Therapeutics
CDTX
|
+$10.5M |
| 2 |
Apogee Therapeutics
APGE
|
+$10.1M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$8.15M |
| 4 |
Insmed
INSM
|
+$7.95M |
| 5 |
Cogent Biosciences
COGT
|
+$7.44M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$14M |
| 2 |
Tarsus Pharmaceuticals
TARS
|
+$11.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
+$10.1M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$7.86M |
| 5 |
Scholar Rock
SRRK
|
+$6.91M |
Sector Composition
| 1 | Healthcare | 99.76% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Teladoc Health
TDOC
$1.37B
| – | – |
-150,000
| Closed | -$1.19M |
|
152
Teva Pharmaceuticals
TEVA
$22.8B
| – | – |
0
| – | – |
|
|
THRD
153
DELISTED
Third Harmonic Bio
THRD
| – | – |
-100,000
| Closed | -$347K |
|
154
Trupanion
TRUP
$1.86B
| – | – |
0
| – | – |
|
155
Trevi Therapeutics
TRVI
$1.17B
| – | – |
-575,000
| Closed | -$3.62M |
|
156
Tyra Biosciences
TYRA
$635M
| – | – |
-35,000
| Closed | -$326K |
|
|
VERV
157
DELISTED
Verve Therapeutics
VERV
| – | – |
-358,393
| Closed | -$1.64M |
|
|
PTHS
158
Pelthos Therapeutics Inc.
PTHS
$94.3M
| – | – |
-44,085
| Closed | -$626K |
|
|
CLYM
159
Climb Bio, Inc. Common Stock
CLYM
$161M
| – | – |
-175,088
| Closed | -$214K |
|
|
OKUR
160
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.8M
| – | – |
-253,754
| Closed | -$1.09M |
|